Terephthalic Acid

Terephthalic Acid

SCHEMBL1008962

O=C([O-])c1ccc(C(=O)[O-])cc1.O=C([O-])c1ccc(C(=O)[O-])cc1.[Zr+4]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Terephthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 18/20 0.68
▸ CA1 P00915 17/20 0.68
▸ CA4 P22748 1/20 0.63
▸ TP53 P04637 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terephthalic Acid SCHEMBL108475 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL10898181 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL9253149 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL1010631 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL20704875 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL1008761 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL6664068 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL3163862 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL21958268 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR
Terephthalic Acid SCHEMBL1535444 0.93 CA2 (0.68) CA2CA1CA4TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117089345-B Water response color change CsPbBr3Quantum dot/MOF material, reversible luminescence method and preparation method 昆明理工大学 2024-05-28 — — CN claimed
CN-117602699-A Photocatalysis method for removing antibiotics in wastewater 太原科技大学 2024-02-27 — — CN claimed
CN-117580639-A Method for preparing metal-organic frameworks using precursors and crystallization aids 埃克森美孚技术与工程公司 2024-02-20 — — CN claimed
CN-115646478-B ZrO (ZrO-like grain) 2 @In 2 O 3 Preparation method of heterostructure catalyst and catalyst for catalyzing CO 2 Application of hydrogenation to methanol preparation 南开大学 2024-01-26 — — CN claimed
CN-117089345-A Water response color change CsPbBr 3 Quantum dot/MOF material, reversible luminescence method and preparation method 昆明理工大学 2023-11-21 — — CN claimed
US-11715864-B2 Metal-organic-framework (MOF) coated composite separators for electrochemical devices and applications of same FORD CHEER INTERNATIONAL LIMITED (VG) 2023-08-01 — — US claimed
CN-115646478-A ZrO (ZrO) 2 @In 2 O 3 Preparation method of heterostructure catalyst and application of heterostructure catalyst in CO catalysis 2 Application of hydrogenation in methanol preparation 南开大学 2023-01-31 — — CN claimed
CN-113817236-A Method for preparing temperature-sensitive flexible sensor from bio-based gutta-percha 沈阳化工大学 2021-12-21 — — CN claimed
CN-109642094-B Composite material 巴斯夫欧洲公司 2021-09-14 — — CN claimed
EP-3504277-B1 COMPOSITE MATERIALS BASF SE (DE) 2020-10-07 — — EP claimed
EP-3504277-A1 COMPOSITE MATERIALS BASF SE (DE) 2019-07-03 — — EP claimed
WO-2018036997-A1 COMPOSITE MATERIALS BASF SE (DE) 2018-03-01 — — WO claimed
US-9038409-B2 Apparatus for treating air by using porous organic-inorganic hybrid materials as an absorbent KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2015-05-26 — — US claimed
US-20110067426-A1 Apparatus for Treating Air KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KP) 2011-03-24 — — US claimed
WO-2026100858-A1 POLYMER FILM COMPRISING POLYMER NANOFIBERS LOADED WITH METAL-ORGANIC FRAMEWORKS, TRIBOELECTRIC-BASED NANOGENERATOR COMPRISING SAME, AND METHOD FOR MANUFACTURING POLYMER NANOFIBERS LOADED WITH METAL-ORGANIC FRAMEWORKS 서울대학교산학협력단 2026-05-15 — — WO disclosed
US-12512310-B2 Porous materials for enhanced ionization efficiency BATTELLE MEMORIAL INSTITUTE (US) 2025-12-30 — — US disclosed
US-12319594-B2 Composition and method for capture and degradation of PFAS BATTELLE MEMORIAL INSTITUTE (US) 2025-06-03 — — US disclosed
WO-2009130251-A2 GAS ADSORBENT FACULTE POLYTECHNIQUE DE MONS (BE) 2009-10-29 — — WO disclosed
US-20090198079-A1 PROCESS FOR PREPARING METAL ORGANIC FRAMEWORKS COMPRISING METALS OF TRANSITION GROUP IV BASF SE 2009-08-06 — — US disclosed
CN-101426797-A Method for producing metal-organic framework materials containing metals of transition group IV BASF SE (DE) 2009-05-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12512310-B2 Porous materials for enhanced ionization efficiency INTS9, SRMS, TPR CA2 1262/4885CA1 463/4885CA4 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback